| Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial AV Balar, MD Galsky, JE Rosenberg, T Powles, DP Petrylak, J Bellmunt, ... The Lancet 389 (10064), 67-76, 2017 | 2088 | 2017 |
| Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3 … BI Rini, T Powles, MB Atkins, B Escudier, DF McDermott, C Suarez, ... The Lancet 393 (10189), 2404-2415, 2019 | 899 | 2019 |
| IMmotion151: a randomized phase III study of atezolizumab plus bevacizumab vs sunitinib in untreated metastatic renal cell carcinoma (mRCC) RJ Motzer, T Powles, MB Atkins, B Escudier, DF McDermott, C Suarez, ... J Clin Oncol 36 (6_suppl), 578, 2018 | 224 | 2018 |
| Statistical strategies for constructing health risk models with multiple pollutants and their interactions: possible choices and comparisons Z Sun, Y Tao, S Li, KK Ferguson, JD Meeker, SK Park, SA Batterman, ... Environmental Health 12, 1-19, 2013 | 164 | 2013 |
| Association of daily asthma emergency department visits and hospital admissions with ambient air pollutants among the pediatric Medicaid population in Detroit: time-series and … S Li, S Batterman, E Wasilevich, R Wahl, J Wirth, FC Su, B Mukherjee Environmental research 111 (8), 1137-1147, 2011 | 98 | 2011 |
| Molecular correlates differentiate response to atezolizumab (atezo)+ bevacizumab (bev) vs sunitinib (sun): results from a phase III study (IMmotion151) in untreated metastatic … BI Rini, M Huseni, MB Atkins, DF McDermott, TB Powles, B Escudier, ... Annals of Oncology 29, viii724-viii725, 2018 | 84 | 2018 |
| Asthma exacerbation and proximity of residence to major roads: a population-based matched case-control study among the pediatric Medicaid population in Detroit, Michigan S Li, S Batterman, E Wasilevich, H Elasaad, R Wahl, B Mukherjee Environmental Health 10, 1-10, 2011 | 74 | 2011 |
| Personal exposure to mixtures of volatile organic compounds: modeling and further analysis of the RIOPA data S Batterman, FC Su, S Li, B Mukherjee, C Jia Research report (Health Effects Institute), 3, 2014 | 72 | 2014 |
| Associations between extreme precipitation and gastrointestinal-related hospital admissions in Chennai, India KF Bush, MS O’Neill, S Li, B Mukherjee, H Hu, S Ghosh, K Balakrishnan Environmental health perspectives 122 (3), 249-254, 2014 | 67 | 2014 |
| IMvigor210 Study Group Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm … AV Balar, MD Galsky, JE Rosenberg, T Powles, DP Petrylak, J Bellmunt, ... Lancet 389 (10064), 67-76, 2017 | 53 | 2017 |
| The effect of crystallinity on the physical properties of UHMWPE AR Champion, S Li, K Saum, E Howard, W Simmons Trans Orthop Res Soc 19, 585, 1994 | 40 | 1994 |
| Neutropenia and thrombocytopenia during treatment as biomarkers of sunitinib efficacy in patients with metastatic renal cell carcinoma (mRCC) F Donskov, A Carus, CH Barrios, B Escudier, S Li, J Perkins, RJ Motzer European Journal of Cancer 47 (Suppl 1), S136, 2011 | 27 | 2011 |
| Comparative effectiveness of non-cisplatin first-line therapies for metastatic urothelial carcinoma: phase 2 IMvigor210 study versus US patients treated in the Veterans Health … N Vander Velde, A Guerin, R Ionescu-Ittu, S Shi, EQ Wu, SW Lin, LI Hsu, ... European Urology Oncology 2 (1), 12-20, 2019 | 22 | 2019 |
| Extreme precipitation and beach closures in the Great Lakes region: evaluating risk among the elderly KF Bush, CL Fossani, S Li, B Mukherjee, CJ Gronlund, MS O’Neill International Journal of Environmental Research and Public Health 11 (2 …, 2014 | 21 | 2014 |
| Oxidation of UHMWPE over long time periods S Li, KA Saum, JP Collier, D Kasprazek ANNUAL MEETING-SOCIETY FOR BIOMATERIALS IN CONJUNCTION WITH THE …, 1994 | 14 | 1994 |
| The Role of Environmental Heterogeneity in Meta‐Analysis of Gene–Environment Interactions With Quantitative Traits S Li, B Mukherjee, JMG Taylor, KM Rice, X Wen, JD Rice, HM Stringham, ... Genetic epidemiology 38 (5), 416-429, 2014 | 13 | 2014 |
| Neutropenia as a biomarker of sunitinib efficacy in patients (Pts) with Gastrointestinal Stromal Tumour (GIST) F Donskov, M Von Mehren, A Carus, S George, PG Casali, S Li, J Perkins, ... European Journal of Cancer 47 (Suppl 1), s135, 2011 | 9 | 2011 |
| Molecular correlates differentiate response to atezolizumab+ bevacizumab vs sunitinib: results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma BI Rini, M Huseni, MB Atkins, DF McDermott, T Powles, B Escudier, ... Ann Oncol 29 (Suppl 8), LBA31, 2018 | 8 | 2018 |
| Addressing extrema and censoring in pollutant and exposure data using mixture of normal distributions S Li, S Batterman, FC Su, B Mukherjee Atmospheric Environment 77, 464-473, 2013 | 8 | 2013 |
| Atezolizumab (atezo) in platinum-treated locally advanced or metastatic urothelial carcinoma (mUC): Outcomes by prior therapy. JL Perez-Gracia, Y Loriot, JE Rosenberg, T Powles, A Necchi, ... Journal of Clinical Oncology 35 (6_suppl), 323-323, 2017 | 7 | 2017 |
